Roche Holding AG ROG-CH:Swiss Exchange

*Data is delayed | CHF

Last | 1:45 PM CEST

303.10

+3.55 (+1.19%)

Volume

350,970

52 week range

290.55 - 356.50

...

Loading . . .

Open299.95
Day High303.20
Day Low299.35
Prev Close299.55
52 Week High356.50
52 Week High Date05/18/20
52 Week Low290.55
52 Week Low Date10/30/20

Key Stats

Market Cap280,139.2M
Shares Out853.13M
10 Day Average Volume1.12M
Dividend9.10
Dividend Yield3.00%
Beta0.08
YTD % Change-1.91

KEY STATS

Open299.95
Day High303.20
Day Low299.35
Prev Close299.55
52 Week High356.50
52 Week High Date05/18/20
52 Week Low290.55
52 Week Low Date10/30/20
Market Cap280,139.2M
Shares Out853.13M
10 Day Average Volume1.12M
Dividend9.10
Dividend Yield3.00%
Beta0.08
YTD % Change-1.91

RATIOS/PROFITABILITY

EPS (TTM)16.52
P/E (TTM)18.35
Fwd P/E (NTM)-
EBITDA (MRQ)-
ROE (MRQ)-
Revenue (MRQ)-
Gross Margin (MRQ)-
Net Margin (MRQ)-
Debt To Equity (MRQ)-

EVENTS

Earnings Date-
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Roche Holding AG

European markets close higher as traders monitor earnings; Heineken shares up 5%April 21, 2021CNBC.com
We're really excited that these genomics companies, says Ark's Simon BarnettApril 12, 2021CNBC.com
Invitae one of our highest conviction names, says Ark's Simon BarnettApril 12, 2021CNBC.com
44. Ginkgo BioworksJune 16, 2020CNBC.com

Latest From Our Partners

Tekla Funds: In A World That Needs Healthcare, These Funds Have A Place In A PortfolioMay 4, 2021Seeking Alpha
ClearBridge International Value Strategy Portfolio Manager Commentary Q1 2021May 4, 2021Seeking Alpha
FDA panel votes to keep indications for Merck, Roche bladder cancer drugsApril 30, 2021Seeking Alpha
FDA panel votes to maintain breast cancer indication for Roche's TecentriqApril 27, 2021Seeking Alpha
Merger Arbitrage Mondays - Bank Mergers DominateApril 26, 2021Seeking Alpha

Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including...

Christoph Franz Ph.D.

Non-Executive Chairman

Alan Hippe

Chief Financial Officer

Claudia Boeckstiegel

General Counsel

Address

Grenzacherstr. 124

Basel

4058

Switzerland

http://www.roche.com